Please use this identifier to cite or link to this item: https://repositorio.uca.edu.ar/handle/123456789/9542
Título : Neuropsychiatric symptoms related to cholinergic deficits in Parkinson’s disease
Autor : Pérez Lloret, Santiago 
Peralta, María Cecilia 
Barrantes, Francisco José 
Palabras clave : ENFERMEDAD DE PARKINSONNEUROTRANSMISORESENFERMEDADES NEUROGENERATIVASTRATAMIENTO MEDICO
Fecha de publicación : 2017
Editorial : Springer Nature
Cita : Pérez Lloret, S., Peralta, M. C., Barrantes, F. J. Neuropsychiatric symptoms related to cholinergic deficits in Parkinson’s disease [en línea]. En: Gargiulo P., Mesones-Arroyo H. (eds.). Psychiatry and Neuroscience Update. Vol. II. Springer : Cham, 2017. doi:10.1007/978-3-319-17103-6 . Disponible en: https://repositorio.uca.edu.ar/handle/123456789/9542
Resumen : Abstract: Given its ability to explain the most frequent motor symptoms of Parkinson’s disease (PD), degeneration of dopaminergic neurons has been considered one of the disease´s main pathophysiological features. Several studies have shown that neurodegeneration also affects noradrenergic, serotoninergic, cholinergic and other monoaminergic neuronal populations. In this work, the characteristic contribution of cholinergic deficits to cognitive dysfunction, psychosis and sleep disturbances in PD and their treatment will be explored. Important neurophysiological processes at the root of several motor and cognitive functions remit to cholinergic neurotransmission at the synaptic pathway and circuital levels. The bulk of evidence highlights the link between cholinergic alterations and the aforementioned symptoms. The pathophysiology of these symptoms is related to degeneration of cholinergic nuclei, most importantly the nucleus basalis magnocellularis and the pedunculo-pontine nucleus. Rivastigmine, a drug that increases cholinergic tone by inhibiting the enzyme cholinesterase, is effective for dementia, whereas the use of Donepezil is still in the realm of investigation. Evidence on the clinical effects of these drugs for psychosis and REM-sleep disturbances is still weak. Anticholinergic drugs should be used with caution in PD, as they may aggravate these cholinergic symptoms.
URI : https://repositorio.uca.edu.ar/handle/123456789/9542
ISBN : 978-3-319-17103-6
Disciplina: MEDICINA
DOI: 10.1007/978-3-319-17103-6
Derechos: Acceso abierto
Appears in Collections:Libros o partes de libro

Files in This Item:
File Description SizeFormat
neuropsychiatric-symptoms-related-cholinergic.pdf622,44 kBAdobe PDFThumbnail
View/Open
Show full item record

Page view(s)

43
checked on Mar 4, 2021

Download(s)

61
checked on Mar 4, 2021

Google ScholarTM

Check


Altmetric


This item is licensed under a Creative Commons License Creative Commons